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oriLyt, the cis-acting element of the lytic origin of DNA replication of Epstein–Barr virus, is activated by the viral transactiva-
tor BZLF1 which belongs to the extended bZIP class of transcription factors. Seven binding sites for BZLF1, so-called ZRE
sites, are located within oriLyt. By mutational analysis of individual ZRE sites, we found that lytic DNA replication is dependent
on only four of these sites which colocate with the promoter of the BHLF1 gene. The remaining three ZRE sites distal to
the BHLF1 promoter were dispensable for DNA replication and did not contribute to long-range transcriptional activation
of this promoter by BZLF1. This finding indicated that a similar set of ZRE sites is involved in DNA replication and transcrip-
tional activation. To determine the function of BZLF1 in DNA replication, BZLF1 mutants with successive deletions in the
transactivation domain were analyzed in replication assays. Unexpectedly, most BZLF1 mutants which failed to support
DNA replication were found to be equally defective in transcriptional activation. Therefore, similar trans-acting domains of
BZLF1 are involved both in replication and in transcription. q 1996 Academic Press, Inc.
INTRODUCTION eukaryotic replication systems is different (DePamphilis,
1993; van der Vliet, 1991; for reviews) but it is still unclear
In eukaryotic origins of DNA replication, transcriptional how transcriptional elements facilitate replication, al-
cis- and trans-acting elements are involved in the regula- though an interaction between the transcription factors
tion of replication (DePamphilis, 1993; Heintz, 1992; for VP16 and Gal4 and replication factor A has been de-
reviews). The link between transcription and replication scribed recently (He et al., 1993; Li and Botchan, 1993).
is unclear but the two mechanisms utilize particular en- We are interested in the origin of DNA replication
hancer-binding proteins to activate both processes. One which drives the amplification of the herpesvirus genome
role for enhancer-binding proteins in regulating replica- of Epstein–Barr virus (EBV) during its lytic life cycle
tion and transcription could be their effect on the chroma- (Hammerschmidt and Mankertz, 1991; for a review). This
tin structure (Felsenfeld, 1992; for a review). A second origin, called oriLyt, is structurally complex and is made
role for this class of proteins could be to interact with up of two core components and several auxiliary regions
the basal replication as well as the basal transcription which are only poorly defined (Hammerschmidt and Sug-
apparatus. Both functions involve distinct families of gen- den, 1988; Schepers et al., 1993b). oriLyt is located within
eral factors, each of them responsible for the assembly the promoter regions of the BHLF1 and BHRF1 genes,
of a multicomponent protein complex at initiation sites which are transcriptionally activated during the early lytic
(Conaway and Conaway, 1993; Kornberg and Baker, phase of EBV by viral transcription factors (Chavrier et
1992; Stillman, 1989; for reviews). al., 1989; Chevallier-Greco et al., 1989, 1986; Cox et al.,
The ability of transcription factors to activate viral or 1990; Gruffat et al., 1990; Hardwick et al., 1988; Laux et
cellular DNA replication is well documented. A number al., 1985; Lieberman et al., 1989, 1990). A crucial factor
of transcription factors activate DNA replication under for this activation is the product of the viral BZLF1 gene
certain conditions; these include NF1/CTF (Cheng and which is also called EB1, zta, Z, or ZEBRA. One of the two
Kelly, 1989), AP-1 (Guo and DePamphilis, 1992), OTF-1 essential components of oriLyt, the upstream component
(Oct-1) (O’Neill et al., 1988), VP16 (Haigh et al., 1990), (Fig. 1), is nearly identical with the BHLF1 promoter which
Gal4 (Bennett-Cook and Hassell, 1991), E2 (Kuo et al., is transactivated directly by BZLF1 (Chavrier et al., 1989;
1994; Melendy et al., 1995; Ustav et al., 1993; Yang et al., Chevallier-Greco et al., 1989, 1986; Cox et al., 1990;
1991), and ABF1 (Diffley and Stillman, 1989). The mode by Gruffat et al., 1990; Hardwick et al., 1988; Laux et al.,
which the transcription factors interact with the different 1985; Lieberman et al., 1989, 1990). BZLF1 belongs to
the bZIP class of transcription factors with homologies
to the AP-1 family (Chang et al., 1990; Farrell et al., 1989;1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /49/89/7099-500. E-mail: hammers@gsf.de. Flemington and Speck, 1990; Flemington et al., 1992;
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FIG. 1. Replication efficiency of oriLyt mutant plasmids with different combinations of functional ZRE sites. (A) oriLyt is located in a divergently
transcribed promoter region which is shown schematically at the top. The fine structure of oriLyt encompassing the functional cis-acting elements
is depicted. The flanking genes BHLF1 and BHRF1 are schematically shown on the left and right (black boxes). The upstream component (nucleotides
52,811 to 52,877; Baer et al., 1984) consists of a cluster of functional redundant elements in cis, including basal promoter elements of the BHLF1-
gene (TATA box, CCAAT box) and two binding sites for the EBV transactivator BZLF1 (ZRE1 and ZRE2). Two further ZRE sites are located in close
vicinity (ZRE3 and ZRE4). The downstream component of oriLyt (nucleotides 53,341 to 53,428) is located 530 bp downstream and contains two
binding sites for the ubiquitous transcription factor Sp1 or Sp1-related proteins (Gruffat et al., 1995). Within the downstream component a 40-bp-
long region could be identified (nucleotides 53,555 to 53,595), which shows in transient replication assays a remarkable sensitivity to point mutations
(Gruffat et al., 1995; Schepers et al., 1993b). Between the downstream component and the BHRF gene are three additional binding sites for BZLF1
(ZRE5 to ZRE7) and two binding motifs for the EBV transactivator R and one for the cellular transcription factor MLTF (Ryon et al., 1993) (not shown).
The different mutants of oriLyt in which combinations of certain ZRE sites were replaced by Gal4- or E2-binding sites are presented underneath;
the black bars indicate either Gal4 or E2 sites. As a consequence, each mutant plasmid exists in two versions carrying either Gal4 or E2 sites as
listed in two columns on the left. Mean values of the relative replication efficiency of oriLyt mutant plasmids are summarized in the two columns
on the right, the standard deviation was about {20% of the mean values. Examples of the experimental data for the Gal4 and E2 replacement
mutants are shown in B and C, respectively. On the left of the autoradiograms, the replication activity of the wild-type oriLyt plasmid p968.22 is
shown. As an internal control which was used to correct for transfection efficiency the wild-type oriLyt plasmid p526 (Hammerschmidt and Sugden,
1988) was used in all transfections and its position on the autoradiograms is indicated. The signal strength of the individual oriLyt plasmids is a
relative measure of the efficiency with which the oriLyt mutants replicated. The number of the plasmids refer to the mutant plasmids listed in A.
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Taylor et al., 1991) and acts as a homodimer and binds in the transactivation domain. Unexpectedly, we found
that regions critical for BZLF1-mediated DNA replicationto specific DNA sequence motifs, mostly called ZRE sites
(BZLF1-responsible-elements) (Chang et al., 1990; Farrell were nearly identical with regions which have been iden-
tified previously to be crucial for transcriptional activationet al., 1989; Kouzarides et al., 1991; Lieberman et al.,
1990; Taylor et al., 1991). In the oriLyt region, BZLF1 binds of BZLF1-dependent promoters. This finding indicates
that BZLF1 might utilize the same cofactors for DNA repli-to seven sites, ZRE1 to ZRE7 (Fig. 1). Two of them (ZRE1
and ZRE2) are located in the upstream component, be- cation and transcriptional activation.
tween the TATA box and the CCAAT box of the BHLF1
promoter, ZRE3 and ZRE4 are located directly adjacent, MATERIAL AND METHODS
whereas ZRE5 to ZRE7 are located beyond the down-
Cell linesstream component of oriLyt (Gruffat et al., 1995; Schepers
et al., 1993b) and near the promoter of the BHRF1 gene D98HR1 cells were derived from a somatic cell hybrid
(Fig. 1). The consensus sequence of BZLF1 is quite vari- between the EBV-genome-positive Burkitt’s lymphoma
able (Chang et al., 1990; Kouzarides et al., 1991) and cell line P3HR1 and the human epithelial cell line D98
consequently the binding affinity of BZLF1 to these ZRE (Glaser and Nonoyama, 1974). This adherent cell line
sites differs (Giot et al., 1991; Gruffat et al., 1990; Lieber- contains approximately 20 copies of the EBV genome
man et al., 1990). One function of BZLF1 is to interact (data not shown) and was maintained in Dulbecco’s mod-
with the general transcription factor TFIID that binds to ified Eagle’s medium containing 5% fetal and 5% newborn
the TATA box of the BHLF1 promoter (Chi and Carey, calf serum. DG75 is an EBV-negative Burkitt lymphoma
1993; Chi et al., 1995; Lieberman and Berk, 1991). In cell line (Ben Bassat et al., 1977) which was grown in
addition, BZLF1 interacts with TFIID-associated factors RPMI 1640 medium supplemented with 5% fetal and 5%
(TAFs) and stabilizes the formation of the transcription newborn calf medium.
initiation complex (Lieberman et al., 1994). Moreover,
BZLF1 is the essential molecular switch for the induction Recombinant plasmids
of the lytic cycle of EBV’s life cycle (Countryman and
Miller, 1985; Takada et al., 1986) and is also indispens- The plasmid p968.22 carrying wild-type oriLyt was con-
structed by ligating a 7.2-kb BamHI/SalI fragment fromable for the activation of oriLyt (Fixman and Hayward,
1995; Schepers et al., 1993a). the EBV strain B95-8 (nucleotide coordinates 48,848 to
56,084) (Baer et al., 1984) into a BamHI/SalI-cut pUC8The binding of BZLF1 to the ZRE sites within oriLyt
has been found to be crucial for oriLyt function (Fixman vector plasmid as described (Schepers et al., 1993b).
The plasmid pCMV-BZLF1 is an expression vector whichand Hayward, 1995; Schepers et al., 1993a). This obser-
vation indicated that the molecular basis of BZLF1 func- efficiently induces the lytic phase of EBV’s life cycle. The
BZLF1 gene is expressed in this retroviral vector con-tion could be the formation of a higher order complex to
activate oriLyt. Such a complex could consist of BZLF1 struct from the promoter of the immediate early genes
of the human cytomegalovirus as described (Ham-molecules which link the seven ZRE sites over a distance
of approximately 900 bp to distort the origin similar to merschmidt and Sugden, 1988). Mutants of p968.22 were
constructed by oligonucleotide-directed mutagenesis aswhat had been demonstrated for the plasmid origin of
DNA replication of EBV (Frappier and O’Donnell, 1991; described in detail (Schepers et al., 1993b). All mutations
were confirmed by DNA sequencing. Synthetic oligonu-Mackey et al., 1995). In order to test this hypothesis we
mutated and replaced the ZRE sites within oriLyt with cleotides for mutagenesis were purchased and purified
on reverse-phase columns through high-pressure liquiddifferent combinations of nonfunctional sites. DNA repli-
cation was found to be dependent on four sites (ZRE1 chromatography. To perform the transient transcription
assays, the 3.8-kb SacII/EcoRI fragment of p968.22 (fromto ZRE4), exclusively, which form a cluster within or in
very close vicinity to the upstream component of oriLyt. 52,623 of EBV to the multiple cloning site in p968.22)
carrying the BHLF1 open reading frame was replaced byTherefore, it is unlikely that BZLF1 activates lytic DNA
replication by a simple conformational change of oriLyt. the luciferase gene which was used as a reporter gene
(de Wet et al., 1987).Rather it appears that the cluster of four BZLF1 binding
sites and a yet to be identified factor (or factors) at the The BZLF1:E2 chimeric transcription factor which con-
sists of the transactivation domain of BZLF1 (aa 1 to 169upstream component are crucial to provide functions
which turn BZLF1 into a replication factor. of BZLF1) and the DNA binding and dimerization domain
of the bovine papillomavirus factor E2 (aa 218 to 410 ofWe have shown previously that the transactivation do-
main of BZLF1 is important to activate oriLyt DNA replica- E2) was cloned under the control of the human cytomeg-
alovirus immediate early promoter as described pre-tion, indicating that this domain might contact other trans-
acting factors (Schepers et al., 1993a). To determine po- viously (pCMV-BZLF1:E2) (Schepers et al., 1993a). Simi-
larly, the chimeric transcription factor Gal4:BZLF1 con-tential protein–protein interaction motifs, we designed a
set of chimeric BZLF1 mutants with successive deletions sisting of the Gal4 DNA binding domain (aa 1 to 141)
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fused to the transactivation domain of BZLF1 (aa 3 to ries of mutants (Fig. 1A). These oriLyt plasmids were
tested in a transient replication assay in D98HR1 cells169) is expressed from the same promoter (pCMV-
Gal4:BZLF1). Internal deletion mutants of BZLF1:E2 and which are latently infected with EBV. Together with the
oriLyt mutant plasmid an oriLyt wild-type plasmid of dif-Gal4:BZLF1 were generated by oligonucleotide-directed
mutagenesis. An additional SpeI site was introduced to ferent size (p526) and a BZLF1 expression plasmid
(pCMV-BZLF1) were cotransfected. pCMV-BZLF1 in-replace the deleted region and to monitor the deletion.
The mutants and their deletions are depicted in Fig. 3A. duces the lytic phase of EBV’s life cycle to provide all
viral functions in trans. BZLF1 also binds to ZRE sites
Transient replication assays within oriLyt; however, wild-type BZLF1 is unable to inter-
act with either Gal4- or E2-binding sites. Two days afterTransient replication assays were performed in
electroporation, low molecular weight DNA was pre-D98HR1 cells by cotransfection of 10 mg of oriLyt wild-
pared and digested with BamHI and DpnI to linearize thetype (p968.22) or mutant plasmid DNA together with an
plasmid DNA and to discriminate between input DNAinternal oriLyt standard plasmid (p526, 1 mg) and 10 mg
and newly replicated DNA. The replication activity ofof pCMV-BZLF1 which efficiently induces the lytic cycle
each oriLyt mutant was detected by Southern blot hybrid-of EBV. In order to analyze BZLF1 mutants, the chimeric
ization with radioactively labeled prokaryotic sequencespCMV-BZLF1:E2 plasmid or a mutant was cotransfected
as described previously (Hammerschmidt and Sugden,as a fourth plasmid. Two days after plasmid transfection
1988; Schepers et al., 1993b).cellular DNA was isolated and input plasmid DNA was
Examples of the transient replication assays whichdigested with DpnI and BamHI (Hammerschmidt and
were performed in triplicate are shown in Fig. 1B (ZRESugden, 1988; Schepers et al., 1993b). The efficiency with
sites replaced with Gal4 sites) and Fig. 1C (ZRE siteswhich the oriLyt plasmids replicated was determined
replaced with E2 sites). The replication efficiencies of 24after Southern blot hybridization and autoradiography by
mutants are summarized in Fig. 1A. As expected, thescanning the specific fragment signals with the aid of a
Gal4 and E2 series of oriLyt mutants gave almost identi-Phosphormager (Fuji). The quantification of the replica-
cal results which demonstrated that the BZLF1-bindingtion assays was based on at least three independent
sites ZRE1 to ZRE4 alone are necessary and sufficientexperiments.
to activate lytic replication. Mutations which render ZRE5
to ZRE7 nonfunctional have no or only very marginal influ-Transient transcription assays
ence on the replication efficiency, whereas mutations
To measure the transcriptional activation of the BHLF1 of the BZLF1-binding sites ZRE1 to ZRE4 reduce oriLyt-
promoter in different oriLyt mutants, 10 mg of plasmid dependent replication (p1086 and p1108, p1781, p1782).
DNA containing the luciferase reporter gene at the posi- DNA replication was completely undetectable in mutants
tion of the BHLF1 gene was cotransfected into D98HR1 which had no functional ZRE1 to ZRE4 sites (p1361 and
cells together with 10 mg pCMV-BZLF1 and 0.5 mg of p1359, 1377 and 1376, 1374 and 1375; Figs. 1B and 1C).
pCMV-b-gal. The luciferase and b-galactosidase activi- ZRE5 to ZRE7 sites did not contribute to replication func-
ties were measured in cell extracts as described in detail tions when ZRE1 to ZRE4 were mutated (p1361 and
(Schepers et al., 1993b). All reactions were performed at p1359, p1199 and p1200, p1377 and p1376, p1374 and
least in quadruplicate. p1375). The data also suggested that ZRE3 and ZRE4
are, together, at least as important for oriLyt-mediated
RESULTS DNA replication as are ZRE1 and ZRE2, if not more im-
portant.A cluster of four BZLF1 binding sites is required to
activate oriLyt-mediated DNA replication
Transcription and DNA replication of oriLyt
Seven binding sites for BZLF1 are located within oriLyt are activated by similar combinations
(Fig. 1A) and lytic DNA replication was abolished when of BZLF1-binding sites
all seven ZRE sites were rendered nonfunctional (Schep-
ers et al., 1993a). The biochemical basis for the activation Lytic DNA replication and transcriptional activation of
the BHLF1 and BHRF1 promoters are two independentof oriLyt by BZLF1 is unknown. We hypothesized that
binding of BZLF1 to multiple sites within a stretch of 1.0 processes (Schepers et al., 1993a). Transcriptional activa-
tion of either of the two promoter elements (BHLF1 orkb might cause linking and distortion of the origin which
could be a prerequisite for its activation. To address BHRF1) within oriLyt is not a prerequisite for DNA replica-
tion. Nevertheless, both activities share common cis-act-this possibility, we constructed a series of oriLyt mutants
carrying different combinations of functional and non- ing elements and are dependent on BZLF1 (Chang et al.,
1990; Chavrier et al., 1989; Fixman and Hayward, 1995;functional ZRE elements. By oligonucleotide-directed mu-
tagenesis we replaced BZLF1 binding sites with either Gruffat et al., 1990; Hardwick et al., 1988; Laux et al., 1985;
Lieberman et al., 1989, 1990; Schepers et al., 1993a,b).GAL4- or E2-binding sites in two otherwise identical se-
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FIG. 2. Relative transcription activity of the BHLF1 promoter in different ZRE-replacement mutants of oriLyt. The set of oriLyt mutants contains
different combinations of E2- and ZRE-binding sites; a functional site is indicated by ZRE1 through ZRE7, a nonfunctional site is indicated by a
black bar. The oriLyt plasmid which contains seven ZRE sites represents the wild-type origin; mutant A lacks any functional ZRE sites, as shown.
Each mutant was tested in a separate series of experiments with the native BZLF1 protein expressed from the human cytomegalovirus promoter/
enhancer. The results are summarized in the column on the left. Mean values (%) and standard deviations were calculated from at least four
independent experiments.
Since the seven ZRE sites within oriLyt form two clusters a fourfold stimulation of the BHLF1 promoter compared
with wild-type (mutant C). As indicated by the mutants Enear the promoters of BHLF1 (ZRE1 to 4) and BHRF1 (ZRE5
to 7) (Fig. 1A), we argued that these clusters act as sepa- and L, pairwise mutations of ZRE1 and ZRE2 or ZRE3 and
ZRE4 resulted in a much reduced activity on the BHLF1rate modules. oriLyt-mediated DNA replication was found
to be dependent on the cluster of four ZRE sites (ZRE1 promoter. Again, the more distal sites ZRE5 to ZRE7 did
not contribute significantly to the activation of the BHLF1to 4), which supports this assumption. To address this
question, we indirectly measured the promoter activity of promoter (compare mutant B with mutants E through G,
or mutant I with mutants K and L). Little activation fromthe ZRE mutants by replacing the flanking BHLF1 gene
with the luciferase reporter gene. Transcriptional activa- the distal ZRE sites could be detected with mutants lack-
ing ZRE1 to ZRE4 (compare mutant A with mutants Mtion of the BHLF1 promoter was determined in transient
transcription assays in the presence of wild-type BZLF1 through O). The observation that mutants with four func-
tional ZRE elements (mutants C and D) are much moreexpressed from the cytomegalovirus early promoter and
enhancer (Schepers et al., 1993a). The same set of oriLyt active than the wild-type plasmids with seven functional
ZRE sites could mean that the two clusters of ZRE1 tomutants which had been used to analyze DNA replication
(Fig. 1) was the basis for this experiment. Only oriLyt mu- ZRE4 and ZRE5 to ZRE7 sites are regulating each other
negatively. An alternative interpretation is that the reduc-tants which carried different combinations of ZRE- and E2-
binding sites were employed and the results are summa- tion of the number of functional binding sites for BZLF1
ensures the occupation of the remaining motifs. This pos-rized in Fig. 2. In general, the results demonstrated that
transcriptional activation of the BHLF1 promoter is depen- sibility seems to be unlikely since even small amounts
of different BZLF1-expression plasmids (CMV-BZLF1 anddent on ZRE sites which had also been found to be essen-
tial for DNA replication. The four proximal sites ZRE1 to SV40-BZLF1) are able to support the full BHLF1-promoter
activity (data not shown).ZRE4 are critical; mutation of ZRE5 to ZRE7 even caused
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These data confirmed that BZLF1 has properties of (Fig. 3A) which might cause misfolding of the BZLF1 part
in case of certain carboxy-terminal mutations. Thesea genuine promoter factor which is a well-documented
characteristic (Chi and Carey, 1993; Lieberman and Berk, structural constraints could also result in proteins having
different binding affinities which would translate into ap-1991; Lieberman et al., 1994). These data show that
BZLF1 cannot co-operate over a fairly long distance, a parent differences in the replication assay. Since the
DNA-binding domain of Gal4 resides within the first 74function which is reminiscent of BZLF1’s contributions to
oriLyt-mediated DNA replication (Fig. 1). Long-range co- amino-terminal residues (Keegan et al., 1986) and the
Gal4:BZLF1 fusion proteins encompass 141 amino acidsoperativity seems to be irrelevant for oriLyt-mediated
DNA replication, suggesting that the upstream compo- of the yeast transcription factor, this assumption seems
to be unlikely. Similarly, the nuclear localization signalsnent of oriLyt with ZRE1 to ZRE4 can now be considered
a functional unit for oriLyt replication. of BZLF1 which reside between aa 140 and aa 165 of
BZLF1 (Mikaelian et al., 1993) should not be required in
our BZLF1:E2 and Gal4:BZLF1 mutants since the respec-Similar domains support replication and transcription
tive DNA-binding domains of either E2 or Gal4 (Silver et
al., 1984) contain functional nuclear localization signalBZLF1 plays a dual role in replication as well as in
transcription. Its transactivation domain is specifically re- sequences. The BZLF1 chimeras showed the expected
sizes and were expressed at about the same levels asquired for DNA replication of oriLyt and cannot be re-
placed by transactivation domains of other transcription indicated in Western blot experiments (data not shown).
In general, these results indicated that similar re-factors which, in contrast, can substitute for BZLF1’s tran-
scription functions (Schepers et al., 1993a). The regions gions within the BZLF1 transactivation domain are
functionally involved in transcription as well as in DNAon the transactivation domain of BZLF1 which support
transcription have been analyzed extensively (Baumann replication.
et al., 1993; Flemington et al., 1992; Giot et al., 1991;
Lieberman and Berk, 1991; Miller et al., 1993). Although DISCUSSION
the results of the independent experiments are not identi-
In this work, three novel aspects of the role of thecal, these investigations demonstrated that two regions
viral transactivator BZLF1 could be described: (i) theof the transactivation domain are important for transcrip-
cluster of four BZLF1-binding sites proximal to thetion: the region located between aa 28 and aa 78, and
BHLF1 promoter is essential and sufficient for oriLyt-between aa 140 and aa 165, the latter containing a nu-
mediated DNA replication; (ii) the domains of theclear localization signal (Fig. 3A for a summary).
BZLF1 protein required for replication are similar toTo determine whether specific regions of the BZLF1
those required for transcriptional activation; and (iii)transactivation domain are important for lytic DNA repli-
BZLF1 has properties reminiscent of a proximal pro-cation, we created a set of chimeric BZLF1:E2 and
moter factor which does not show significant long-Gal4:BZLF1 deletion mutants (Fig. 3A) which were ex-
range cooperation in the context of oriLyt.pressed from the human cytomegalovirus immediate
early promoter. Successive deletions, each comprising oriLyt-mediated DNA replication is specifically
27 aa, were introduced into the transactivation domain of activated by ZRE1 to ZRE4
BZLF1. These chimeras were tested in replication assays
with oriLyt mutant plasmids in which all seven ZRE sites Both the lytic origin of DNA replication and the BHLF1
promoter have cis- and trans-acting elements in com-were replaced by either E2- or Gal4-binding sites (plas-
mids p1199 and p1200 in Fig. 1). The results of the tran- mon. Both functions, replication and transcription, are
dependent on the EBV-specific transactivator BZLF1sient replication assays indicated that the core region
of BZLF1 which supports DNA replication localizes to a which binds seven times within the region of oriLyt (Lie-
berman and Berk, 1990, 1991; Lieberman et al., 1990).domain from aa 27 to aa 78. Deletion from aa 78 to aa
103 of the BZLF1:E2 chimera resulted in a dramatically We have demonstrated earlier that lytic DNA replication
is dependent on a specific function that resides in thereduced activation of DNA replication (Figs. 3A and 3B).
The region between aa 27 and aa 103 within the BZLF1 transactivation domain of BZLF1. In contrast, transcrip-
tional activation of the BHLF1 promoter is promiscuous,transactivation domain could be confirmed in a second
independent series of experiments with Gal4:BZLF1 chi- indicating that DNA replication has more stringent re-
quirements in trans than does mRNA synthesis (Schep-meras, although the results are not identical: Gal4:BZLF1
chimeras with deletions in the BZLF1 transactivation do- ers et al., 1993a). In this report, we show that this specific-
ity also acts in cis. The analysis of oriLyt mutants, withmain up to aa 140 were greatly impaired in their capacity
to support DNA replication (Figs. 3A and 3C, and data various combinations of functional and nonfunctional
ZRE sites, revealed that oriLyt-mediated DNA replicationnot shown). The discrepancy between BZLF1:E2 and
Gal4:BZLF1 could be explained by the completely differ- depends entirely on ZRE1 to ZRE4 (Fig. 1A). Mutational
inactivation of the BZLF1-binding sites ZRE5 to ZRE7 hasent design of the functional modules of the two chimeras
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FIG. 3. oriLyt replication assays with deletion mutants of the chimeric BZLF1:E2 and Gal4:BZLF1 proteins. (A) To determine specific regions of
the BZLF1-transactivation domain which are important for oriLyt-mediated DNA replication, a set of chimeric BZLF1:E2 and Gal4:BZLF1 deletion
mutants was created which were expressed from the immediate early promoter/enhancer of the human cytomegalovirus. Successive deletions of
about 27 aa were introduced into the transactivation domain of the two chimeric transactivators. All chimeric proteins were tested in replication
assays with the aid of two oriLyt mutant plasmids which carry either seven E2-binding sites (p1199) or seven Gal4-binding sites (p1200) (Schepers
et al., 1993a). For comparison, the regions which have been described as important for transcriptional transactivation by BZLF1 are marked with
gray areas ranging from aa 28 to aa 78 and aa 140 to aa 165. The latter region contains a functionally important nuclear localization signal
(Flemington et al., 1992; Giot et al., 1991; Lieberman and Berk, 1991; Miller et al., 1993). (B and C) Transient replication assays with the deletion
mutants of the chimeric BZLF1:E2 and Gal4:BZLF1 fusion proteins. The Southern blots which resulted from transient replication assays with the
oriLyt plasmids p1199 and p1200 and the chimeric BZLF1 deletion mutants indicate the region of BZLF1 which supports DNA replication. An example
of the results with BZLF1:E2 chimeras is shown in B, the analogous results with Gal4:BZLF1 chimeras are shown in C. The results of three
independent experiments were quantitated and the mean values are shown in A. The domain which is essential for replication is located between
aa 27 and aa 103 for BZLF1:E2. The results obtained with the Gal4:BZLF1 mutants indicate that the important domain which supports lytic replication
may extend to aa 140. The data were obtained with (B) the oriLyt mutant plasmid p1199 carrying seven E2-binding sites in the presence of the
chimeric BZLF1:E2 protein or with (C) the oriLyt mutant plasmid p1200 with seven Gal4-binding sites and the chimeric Gal4:BZLF1 protein as
transactivator. The control signals of the oriLyt wild-type plasmid p526 (Hammerschmidt and Sugden, 1988) were used as an internal standard to
correct for transfection efficiencies.
only a marginal influence on DNA replication. This finding replication ZRE1 to ZRE4 are mandatory; distal ZRE sites
contribute little (Fig. 2). For transcriptional activation ofcould mean that BZLF1 is not able to act over a longer
distance and needs to be present in a cluster of binding BHLF1, no obvious hierarchy exists between ZRE1/ZRE2
versus ZRE3/ZRE4 sites despite the fact that they displaysites that is part of the upstream component of oriLyt.
This assumption also holds true for mRNA synthesis be- remarkably different binding affinities for BZLF1 (Lieber-
man and Berk, 1990; Lieberman et al., 1990). For DNAcause the activity of the BHLF1 promoter is dependent on
the same combination of ZRE sites. As in oriLyt-mediated replication, however, ZRE3/ZRE4 which have the lowest
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binding affinity among the ZRE sites of oriLyt are more Whether a similar trans-acting factor exists which has
modulator property specific for DNA replication remainsimportant than ZRE1/ZRE2 (Fig. 1).
The comparison between oriLyt-mediated DNA repli- to be demonstrated. It appears that BZLF1 has evolved
as an omnipotent factor to combine multiple functionscation and activation of the BHLF1 promoter points to
an important finding. It appears that BZLF1 acts as a during the productive lytic phase of EBV’s life cycle.
Moreover, the transcriptional activation domain of BZLF1replication factor only when it is bound to the upstream
component of oriLyt. Deletion analysis of this region indi- seems to be the key element which most likely is en-
gaged in different protein–protein interactions.cated that other DNA sequence motifs besides the four
BZLF1-binding sites might be influential on DNA replica-
tion (Schepers et al., 1993b). This assumption is sup- ACKNOWLEDGMENTS
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